Metraipolis › archive › dc_a68fe6d7db99

Immune checkpoint inhibitor integration in locoregionally advanced nasopharyngeal carcinoma: a prospective evidence synthesis on efficacy, safety, and… — Europe PMC PMID:42433378

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42433378
DOI
10.3389/fimmu.2026.1840292
License (as archived)
solo-consultazione
Archived
2026-10-18T16:58:24.007Z
SHA-256 of the archived text
a4753dcefb2561219eb30b84ea6f92caeb95b2f2eef0c51de30bab2cff54f5bb
Stable URL of this page
https://metraipolis.com/documento/dc_a68fe6d7db99

How to cite

Immune checkpoint inhibitor integration in locoregionally advanced nasopharyngeal carcinoma: a prospective evidence synthesis on efficacy, safety, and… — Europe PMC PMID:42433378 — Europe PMC (en), https://europepmc.org/article/MED/42433378 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a68fe6d7db99 (Metraipolis archive dc_a68fe6d7db99, sha256 a4753dcefb2561219eb30b84ea6f92caeb95b2f2eef0c51de30bab2cff54f5bb)
BibTeX
@misc{dca68fe6d7db99,
  title = {Immune checkpoint inhibitor integration in locoregionally advanced nasopharyngeal carcinoma: a prospective evidence synthesis on efficacy, safety, and… — Europe PMC PMID:42433378},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42433378},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a68fe6d7db99; sha256 a4753dcefb2561219eb30b84ea6f92caeb95b2f2eef0c51de30bab2cff54f5bb},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42433378. Agents can read the archived copy with the MCP tool read_document.